SCM
Superstring Capital Management Portfolio holdings
AUM
$80.3M
This Quarter Return
-20.91%
1 Year Return
+68.23%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$79.3M
AUM Growth
+$79.3M
(-48%)
Cap. Flow
-$38.1M
Cap. Flow
% of AUM
-48.09%
Top 10 Holdings %
Top 10 Hldgs %
66.81%
Holding
58
New
21
Increased
4
Reduced
13
Closed
19
Top Buys
| 1 |
Legend Biotech
LEGN
|
$6.85M |
| 2 |
Terns Pharmaceuticals
TERN
|
$6.51M |
| 3 |
Zai Lab
ZLAB
|
$3.73M |
| 4 |
Arcellx
ACLX
|
$3.26M |
| 5 |
Arrowhead Research
ARWR
|
$2.89M |
Top Sells
| 1 |
IDEAYA Biosciences
IDYA
|
$9.53M |
| 2 |
Savara
SVRA
|
$7.52M |
| 3 |
Day One Biopharmaceuticals
DAWN
|
$5.78M |
| 4 |
Roivant Sciences
ROIV
|
$5.6M |
| 5 |
Ionis Pharmaceuticals
IONS
|
$5.24M |
Sector Composition
| 1 | Healthcare | 99.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Lyra Therapeutics
LYRA
$12.1M
| – | – |
-145,284
| Closed | -$904K |
|
52
Praxis Precision Medicines
PRAX
$941M
| – | – |
-40,119
| Closed | -$2.45M |
|
53
Avidity Biosciences
RNA
$5.96B
| – | – |
-37,031
| Closed | -$945K |
|
|
54
Roivant Sciences
ROIV
$8.38B
| – | – |
-531,019
| Closed | -$5.6M |
|
|
SY
55
So-Young International
SY
$372M
| – | – |
-182,742
| Closed | -$199K |
|
56
UroGen Pharma
URGN
$888M
| – | – |
-288,267
| Closed | -$4.32M |
|
|
VRNA
57
Verona Pharma
VRNA
$9.17B
| – | – |
-259,383
| Closed | -$4.17M |
|
|
ALPN
58
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| – | – |
-9,038
| Closed | -$358K |
|